Bill Moves Forward To Cap Insulin Costs And Curb Patent Abuses
· forbes.com
Bills in Congress could directly lead to lower patient out-of-pocket costs for items like insulin and may indirectly impact expenses by curbing possible patent abuses.
Bills are advancing in Congress that would introduce different forms of drug patent reform. getty
The INSULIN Act successfully passed out of the United States ...